Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LEVANT

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Pharmacological Reviews|October 6, 1997
The D3 dopamine receptor: neurobiology and potential clinical relevanceB Levant
Brain Research|November 6, 1995
Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineB Levant
Brain Research|August 1, 1998
Differential distribution of D3 dopamine receptors in the brains of several mammalian speciesB Levant
Pennsylvania Medical Journal (1928)|October 29, 2010
Intramuscular urographyB LEVANT, J J LEE
Neuroscience Letters|April 12, 2001
D(3) dopamine receptors in rat spinal cord: implications for sensory and motor functionB Levant, K E McCarson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
In vivo occupancy of D2 dopamine receptors by nafadotrideB Levant, N R Vansell
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802B Levant, C B Nemeroff
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudateB Levant, C B Nemeroff
Life Sciences|November 7, 1998
Inhibition of [3H]quinpirole binding by a monoamine oxidase inhibitor in subcellular fractions of rat striatumB Levant, G N Bancroft
Psychopharmacology|March 7, 1998
The D3 dopamine receptor in cellular and organismal functionR A Shafer, B Levant
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Pharmacological Reviews|October 6, 1997
The D3 dopamine receptor: neurobiology and potential clinical relevanceB Levant
Brain Research|November 6, 1995
Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineB Levant
Brain Research|August 1, 1998
Differential distribution of D3 dopamine receptors in the brains of several mammalian speciesB Levant
Pennsylvania Medical Journal (1928)|October 29, 2010
Intramuscular urographyB LEVANT, J J LEE
Neuroscience Letters|April 12, 2001
D(3) dopamine receptors in rat spinal cord: implications for sensory and motor functionB Levant, K E McCarson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
In vivo occupancy of D2 dopamine receptors by nafadotrideB Levant, N R Vansell
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802B Levant, C B Nemeroff
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudateB Levant, C B Nemeroff
Life Sciences|November 7, 1998
Inhibition of [3H]quinpirole binding by a monoamine oxidase inhibitor in subcellular fractions of rat striatumB Levant, G N Bancroft
Psychopharmacology|March 7, 1998
The D3 dopamine receptor in cellular and organismal functionR A Shafer, B Levant
Pageof 4